Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 29, Issue 3, 1998, Pages 480-490

  Pramoolsinsap, Chutima ^a   Poovorawan, Yong ^b   Sura, Thanyachai ^c   Theamboonlers, Apiradee ^b   Busagorn, Nunta ^a   Kurathong, Sucha ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c Med Genetics and Molecular Medicine   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; VIRUS RNA;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; FLAVIVIRUS; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TUMOR; MALE; MIDDLE AGED; VIROLOGY; VIRUS HEPATITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; FLAVIVIRIDAE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0032149482     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Aikawa T, Sugal Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334 : 195-6.
2. Alter HJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997a; 336: 741-6.
3. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997b; 336: 747-54.
4. Bralet MP, Roudot-Thoraval F, Pawlotsky JM, et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997; 112: 188-92.
5. Bukh J, Miller RH. Diagnostic and clinical implications of the different genotypes of hepatitis C virus. Hepatology 1994; 20: 256-9.
6. Cha TA, Kolberg J, Irvine B, et al Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol 1991; 29: 2528-34.
7. DeGroote J, Desmet VJ, Gedick P, et al. Acute and chronic hepatitis revisited. Review by an International Group. Lancet 1977; 2: 914-9.
8. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
9. Diamentis I, Bassetti S, Erb P, et al. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol 1997; 26: 794-7.
10. Feucht HH, Zollner B, Polywka S, et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997;26: 91-4.
11. Francesconi R, Giostra F, Ballardini G, et al. Clinical implications of GBV-C / HGV infection in patients with " HCV-related" chronic hepatitis. J Hepatol 1997; 26: 1165-72.
12. Goeser T, Seipp S, Wahl R, Muller HM, Stremmel W, Theilmann L. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C. J Hepatol 1997; 26: 498-502.
13. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-5.
14. Jeffers U, Piatak M, Bernstein DE, et al. Hepatitis G virus infection in patients with acute and chronic liver disease of unknown etiology (abstract) Hepatology 1996; 22: 182A.
15. Kao JH, Chen PJ, Lai MY, et al. GB virus-C / hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology 1997; 112: 1265-70.
16. Kararayiannis P, Hadziyannis S, Kim J, et al. Hepatitis G virus infection: Clinical characteristics and response to interferon. J Virol Hepatol 1997;4: 44-57.
17. Khudyakov YE, Cong M-E, Bonafonte M-T, et al Sequence variation within a nonstructural region of the hepatitis G virus genome. J Virol 1997, 71: 6875-80.
18. Kobayashi M, Tanaka E, Sodeyama E, et al. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-9.
19. Kubo S, Nishguchi S, Kuroki T, et al. Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol 1997; 27: 91-5.
20. Lau JY, Simmonds P, Urdea M. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995; 346: 425-6.
21. Lefiére JJ, Loiseau P, Maury J, et al. Natural history of GBV-C / hepatitis G virus infection through the follow-up of GBV-C / hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology. Blood 1997; 90: 3776-80
22. Linnen J, Wages J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
23. Loiseau P, Mariotti M, Corbi C, et al. Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion 1997; 37: 645-50.
24. Lopez-Labrador FX, Ampurdanes S, Forns X, et al. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997; 27: 959-65.
25. Marcellin P, Boyer A, Gervais M, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV-RNA in patients with chronic hepatitis C and sustained response to interferon-? therapy. Ann Intern Med 1997; 127: 875-81.
26. Martinot M, Marcellin P, Boyer N, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-α in patients with chronic hepatitis C. Ann Intern Med 1997; 126: 874-81.
27. Martinot-Peignoux M, Marcellin P, Pouteau M, et al Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995; 22: 1050-6.
28. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-90.
29. Nagayama R, Miyake IC, Okamoto H. Effect of interferon on GB virus C and hepatitis C viras in patients with the co-infection. J Med Virol 1997; 52:156-60.
30. Nakatsuji Y, Shih JW, Tanaka E, et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Virol Hepatol 1996; 3: 307-16.
31. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers, application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9.
32. Park YM, Mizokami M, Nakano T, et al. GB virus C / hepatitis G virus infection among Korean patients with liver diseases and general population Virus Res 1997, 48: 185-92.
33. Pawlotsky JM, Roudot-Thoravel F, Pellerin M, et al. GBV-C infection in HCV-infected patients: epidemiological characteristics, influence on HCV infection and response to Interferon alfa therapy. Hepatology 1996; 24: 226A.
34. Pramoolsinsap C, Pukrittayakamee S, Desakorn V. Hepatitis B problem in Thailand Southeast Asian J Trop Med Public Health 1986; 17: 219-28.
35. Pramoolsinsap C. Hepatitis G virus infection. Med Prog 1998; 25: 23-8.
36. Sáiz JC, Ampurdanes S , Olmedo E, et al. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to Interferon therapy. J Hepatol 1997; 26: 787-93.
37. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology 995; 38: 162-9.
38. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564-9.
39. th General Meeting of the American Society for Microbiology, 4-8 May, 1997.
40. Sugai Y, Nakayama H, Fukuda M, et al Infection with GB virus C in patients with chronic liver disease. J Med Virol 1997; 51: 175-81.
41. Takada N, Takase S, Yakada A, Date T. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993; 17: 277-83.
42. Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996; 125: 740-3.
43. Wang HL, Jin DY. Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients. J Infect Dis 1997; 175: 1229-33.
44. Wu CH, Lee MF, Kuo HS. Distribution of hepatitis C virus genotypes among blood donors in Taiwan. J Gastroenterol Hepatol 1997; 12: 625-8.
45. Yamada G, Takatani M, Kishi F, et al. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 1995; 22: 1351-4.
46. Yotsuyanagi H, Koike K, Yasuda K, et al Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer 1995; 76: 1352-5.
47. Zhang YY, Lok ASF, Chan DTM, Widell A. Greater diversity of hepatitis C virus genotypes found in Hong Kong than in Mainland China. J Clin Microbiol 1995; 33: 2931-4.